Camp4 Therapeutics Corporation (CAMP)
NASDAQ: CAMP · Real-Time Price · USD
5.99
0.00 (0.00%)
At close: Jan 6, 2026, 4:00 PM EST
5.99
0.00 (0.00%)
After-hours: Jan 6, 2026, 4:10 PM EST
Camp4 Therapeutics Revenue
Camp4 Therapeutics had revenue of $795.00K in the quarter ending September 30, 2025. This brings the company's revenue in the last twelve months to $3.80M. In the year 2024, Camp4 Therapeutics had annual revenue of $652.00K with 86.29% growth.
Revenue (ttm)
$3.80M
Revenue Growth
+86.29%
P/S Ratio
33.45
Revenue / Employee
$69,127
Employees
55
Market Cap
310.77M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 652.00K | 302.00K | 86.29% |
| Dec 31, 2023 | 350.00K | - | - |
| Dec 31, 2022 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionCAMP News
- 9 hours ago - CAMP4 to Present at the 44th Annual J.P. Morgan Healthcare Conference - GlobeNewsWire
- 19 days ago - CAMP4 Announces Pricing of $30.0 Million Underwritten Offering of Common Stock - GlobeNewsWire
- 19 days ago - CAMP4 and GSK Enter Strategic Collaboration to Advance RNA-Based Therapeutic Discoveries - GlobeNewsWire
- 25 days ago - CAMP4 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 7 weeks ago - CAMP4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 2 months ago - CAMP4 Reports Third Quarter 2025 Financial Results and Corporate Highlights - GlobeNewsWire
- 3 months ago - CAMP4 Therapeutics Initiates GLP Toxicology Studies for CMP-SYNGAP-01 - GlobeNewsWire
- 4 months ago - CAMP4 Announces an Oversubscribed Private Placement of up to $100 Million to Advance First-in-Class Treatment for SYNGAP1-Related Disorders - GlobeNewsWire